Medical treatment of diabetic foot infections

被引:273
作者
Lipsky, BA
机构
[1] VA Puget Sound Hlth Care Syst, Gen Internal Med Clin, Seattle, WA 98108 USA
[2] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA
关键词
D O I
10.1086/383271
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Diabetic foot infections frequently cause morbidity, hospitalization, and amputations. Gram-positive cocci, especially staphylococci and also streptococci, are the predominant pathogens. Chronic or previously treated wounds often yield several microbes on culture, including gram-negative bacilli and anaerobes. Optimal culture specimens are wound tissue taken after debridement. Infection of a wound is defined clinically by the presence of purulent discharge or inflammation; systemic signs and symptoms are often lacking. Only infected wounds require antibiotic therapy, and the agents, route, and duration are predicated on the severity of infection. Mild to moderate infections can usually be treated in the outpatient setting with oral agents; severe infections require hospitalization and parenteral therapy. Empirical therapy must cover gram-positive cocci and should be broad spectrum for severe infections. Definitive therapy depends on culture results and the clinical response. Bone infection is particularly difficult to treat and often requires surgery. Several adjuvant agents may be beneficial in some cases.
引用
收藏
页码:S104 / S114
页数:11
相关论文
共 89 条
[1]   Efficacy of sulbactam-ampicillin for the treatment of severe diabetic foot infections [J].
Akova, M ;
Ozcebe, O ;
Gullu, I ;
Unal, S ;
Gur, D ;
Akalin, S ;
Tokgozoglu, M ;
Telatar, F ;
Akalin, HE .
JOURNAL OF CHEMOTHERAPY, 1996, 8 (04) :284-289
[2]   A SELECTIVE CLINICAL-TRIAL OF CEFTIZOXIME [J].
ANANIA, WC ;
CHINKES, SL ;
ROSEN, RC ;
TURNER, PR ;
HELFAND, AE .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1987, 77 (12) :648-652
[3]  
[Anonymous], 1999, International Code of Zoological Nomenclature, P1
[4]   Validation of a diabetic wound classification system - The contribution of depth, infection, and ischemia to risk of amputation [J].
Armstrong, DG ;
Lavery, LA ;
Harkless, LB .
DIABETES CARE, 1998, 21 (05) :855-859
[5]   Value of white blood cell count with differential in the acute diabetic foot infection [J].
Armstrong, DG ;
Perales, TA ;
Murff, RT ;
Edelson, GW ;
Welchon, JG .
JOURNAL OF THE AMERICAN PODIATRIC MEDICAL ASSOCIATION, 1996, 86 (05) :224-227
[6]   Improvement in healing with aggressive edema reduction after debridement of foot infection in persons with diabetes [J].
Armstrong, DG ;
Nguyen, HC .
ARCHIVES OF SURGERY, 2000, 135 (12) :1405-1409
[7]  
Bakker DJ, 2000, DIABETES-METAB RES, V16, pS55, DOI 10.1002/1520-7560(200009/10)16:1+<::AID-DMRR132>3.0.CO
[8]  
2-T
[9]  
BEAM TR, 1989, REV INFECT DIS, V11, pS1163
[10]  
BREEN JD, 1995, INFECT DIS CLIN N AM, V9, P11